Immuno-Oncology Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Immuno-Oncology Market size was valued at USD 17.56 billion in 2021 and is expected to grow at a CAGR of 23% during the forecast period 2022-2028.

Immuno-oncology (I-O) is an innovative field of study that helps the body’s immune system fight cancer. The goal is to address the unmet need for long-term survival of patients with advanced cancer. I-O therapy is a new type of cancer therapy that uses an individual’s immune system to fight disease. This treatment uses molecules made in the body or in a laboratory to improve the immune system to find and destroy cancer cells. The shift from conventional chemotherapy treatment to immuno-oncology therapy is expected to propel the immuno-oncology (IO) market growth during the forecast period.

Market Segments

By Therapy Type

• Immune Checkpoint Inhibitors
• PD-1
• PD-L1
• CTLA-4
• Immune System Modulators
• Cancer Vaccines
• Oncolytic Virus
• Others (Immune Cell Therapy, etc.)

By Therapeutic Area

• Melanoma
• Lung Cancer
• Blood Cancers
• Renal Cell Carcinoma
• Prostate Cancer
• Bladder Cancer
• Other Cancers

Key Players

• Amgen, Inc.
• AstraZeneca Plc
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi.

Scope of the Report

The research study analyzes the global Immuno-Oncology industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Immuno-Oncology Market Report

1. What was the Immuno-Oncology Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Immuno-Oncology Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Immuno-Oncology Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.